SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-007940
Filing Date
2022-05-06
Accepted
2022-05-05 18:13:03
Documents
68
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rare-20220331.htm   iXBRL 10-Q 2664313
2 EX-10.1 rare-ex10_1.htm EX-10.1 83487
3 EX-31.1 rare-ex31_1.htm EX-31.1 18986
4 EX-31.2 rare-ex31_2.htm EX-31.2 18987
5 EX-32.1 rare-ex32_1.htm EX-32.1 15040
6 GRAPHIC img215001706_0.jpg GRAPHIC 129834
  Complete submission text file 0000950170-22-007940.txt   9017985

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT rare-20220331_cal.xml EX-101.CAL 47371
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20220331_pre.xml EX-101.PRE 289245
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20220331.xsd EX-101.SCH 59989
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20220331_lab.xml EX-101.LAB 393112
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT rare-20220331_def.xml EX-101.DEF 167256
62 EXTRACTED XBRL INSTANCE DOCUMENT rare-20220331_htm.xml XML 1637900
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36276 | Film No.: 22898139
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences